|

Evaluation of Aqueous Humor DEL-1 and IL-17 Levels in Diabetic Cataract Patients

RECRUITINGN/ASponsored by Uşak University
Actively Recruiting
PhaseN/A
SponsorUşak University
Started2025-05-01
Est. completion2025-07-31
Eligibility
Age50 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06995131

Summary

By comparing DEL-1 and IL-17 levels in the aqueous humor of diabetic cataract patients with the aqueous humor of non-diabetic patients, we aim to understand the biochemical effects of diabetes-related inflammatory processes in the eye.

Eligibility

Age: 50 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Cataract diagnosed and surgery planned
* Patients without any other ocular pathology other than cataract.
* Type 2 DM for at least 5 years in the diabetic group

Exclusion Criteria:

* Patients with previous intraocular surgery
* Those with inflammatory eye diseases (e.g. uveitis)
* Those with autoimmune diseases or systemic inflammatory diseases
* Those receiving local or systemic steroid therapy
* Those with severe systemic disease (e.g. advanced renal failure, malignancy)

Conditions3

DiabetesDiabetic Group (n=30)Non-diabetic Group

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.